英文摘要 |
Since its establishment in 1994, the Taipei Exchange (“the Exchange”) has been in charge of regulating Taiwan’s over-the-counter Market (“the OTC Market”). The Exchange prescribes criteria for listing and delisting of securities, promulgates rules to regulate listed companies and securities firms, includung inspection of books, records, and imposition of sanctions. The Exchange has been a de facto Regulator of the OTC Market. The Exchange is organized as a private non-profit Foundation, and has never been authorized by the Securities Exchange Act (“the Act”) to regulate any market. In fact the Act delegates the regulatory authority to the Financial Supervisory Commission (“the Commission”), and the Commission redelegates the authority to the Exchange. The Comission’s redelegation, however, has no legal basis. The Constitutional Court has twice stated that if a statute delegates the competent authority to make the rules and does not provide for a redelegation, the competent authority should promulgate the rules by itself, and cannot redelegate the rule-making power to its subordinate agencies. (J.Y. Interpretation Nos. 524 & 543). The Act does not provide for such a redelegation. The Commission has no authority to redelegate its rule-making power to the Exchange. The current practice is unconstitutional. This Article suggests that the Act be amended to address the problem. |